Skip to content
Catalyst

curcuminFinding

Curcumin decreases visual analogue scale pain intensity

lowersVery limited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“The NMA results showed that compared with placebo, curcumin significantly reduced the visual analogue scale pain score (MD = -1.63, 95% CI: -2.91 to -0.45) and total WOMAC score (MD = -18.85, 95% CI: -29.53 to -8.76).”
Quoted verbatim from Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
This finding among the 19 findings on its endpoint

curcumin

Visual analogue scale pain intensity

lowers

Effect as reported

CI −2.91 to −0.45

Who
Patients with knee osteoarthritis; Bayesian network meta-analysis, the contrast recorded here is curcumin monotherapy versus placebo. The review included 23 studies and 2175 KOA patients across 6 interventions overall; the abstract does not state how many patients or trials fed this particular pairwise estimate. The abstract does not state the VAS anchors, the scale length, or the recall frame.
Dose studied
not reported

Very limited evidencePMID 38036015 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3R2J1BP9DVZJT7AQ422ZCKR